More on private 5G
Bruce Lancaster, CEO, Wilson Connectivity, on the positioning of private 5G as a reliable option for secure, high-capacity and low-latency communication needs.
Cambridge assembles world-class tech and science leaders to steer innovation and growth blueprint
Cambridge: Innovate Cambridge is today unveiling its Advisory Council featuring global tech and science pioneers such as Professor Dame Ottoline Leyser (UKRI), Hermann Hauser (Arm, Amadeus Capital) and Stan Boland (FiveAI, Icera).
Official launch of this year's exciting 2025 Cambridge Dragon Boat Festival
Every year, Fen Ditton plays host to one of the most fun-filled, family-friendly events in the Cambridge calendar - the Cambridge Dragon Boat Festival. This year's event celebrates its 19th year - and marks the 30th birthday year of its host, Addenbrooke's Charitable Trust. With a bigger fundraising target than ever before - with all proceeds going towards the build of the Cambridge Cancer…
New AI tool visualises a cell’s ‘social network’ to help treat cancer
A first-of-its-kind artificial intelligence (AI)-based neural network can rapidly analyse and interpret millions of cells from a patient sample, predicting molecular changes in the tissue. It can potentially pinpoint where personalised treatments could be most effective for conditions such as cancer.
Acne vulgaris vaccines: time for something new
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis, publishes a brand-new global analysis focused on the potential for acne vulgaris vaccines.
Finding Clarity, Support and Momentum as an Innovation Entrepreneur
By Garry Jennings, Innovation Director, The EpiCentre
Sapio Sciences makes AI-native drug discovery seamless with NVIDIA BioNeMo
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle
25 years of working in Mental Health
Claire Harris, Health Psychologist and Founder of Promote Mental Health celebrates working in the mental health field for 25 years. Read this blog for her views on what has changed over the last 25 years, and what she hopes for the future in the mental health sector.
Cambridge scientist launches free VR platform that eliminates the fear of public speaking
Dr Chris Macdonald creates free virtual reality platform that transforms users into skilled and confident public speakers
Living with Pulmonary Arterial Hypertension: Early Diagnosis, Patient Advocacy, and the Role of Technology
Co-authored by Maleen Fischer, PHA Europe
First global pituitary study gives patients voice on research
Researchers from Cambridge and London have completed a study that is a world first of its kind and gives patients an important voice on future priorities.
SolasCure enrols first patient in a next Phase II clinical trial to advance Aurase Wound Gel
Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers
District Council encourages parents to claim free Healthy Start vouchers
Parents of children under the age of four years old are being encouraged to check if they are eligible for free Healthy Start vouchers to help buy food and milk.
New research - Weight loss increases risk of death for obese adults
Study finds significant weight loss raises risk for those with cardiovascular disease.
Unlocking the mysteries of the brain: highlights from the Cambridge Festival
As discussions around mental health and cognitive wellbeing continue to dominate headlines, the Cambridge Festival (19 March - 4 April 2025) offers a timely, in-depth exploration of the brain’s complexities.
CUH appoints a new Non-Executive Director
Mr John Crompton has been appointed as a Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust (CUH), which runs Addenbrooke’s and The Rosie hospitals.
Cellular changes as lung damage worsens in COVID-19 revealed
Changes in the cellular response during lung damage caused by SARS-CoV-2 – the virus behind COVID-19 – have been uncovered. Researchers reveal distinct phases where waves of immune responses give way to lung fibrosis – scarring of the lungs – in severe COVID-19.
Young Carers Action Day – Education Summit 2025
On 12 March 2025, the Young Carers in Education Summit brought together educators, charities and most importantly, young carers from across the region for a day of sharing, learning, and empowerment.
Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing
HERCULES, Calif. — 10 March Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announces the launch of XP-Design Assay Salmonella Serotyping Solution designed for the rapid detection and precise characterization of
WaveFX revolutionises webcasting & event production with a 5-star approach
Let’s be honest, most webcasts are either too complicated, too boring, or both. That’s where WaveFX comes in. They believe event production should be stress-free, engaging, and actually fun (yes, even for corporate events!). Whether it’s a hybrid conference, awards show, product launch, or live stream, we bring a fresh, people-first approach that keeps audiences watching.
Arecor establishes partnership with biopharmaceutical company to develop novel formulation of peptide therapy
Partner to fund development work with option to acquire rights to proprietary formulation under Arecor’s technology licensing model.
H.E.L Group signs research agreement with the Institute of Chemical Technology (ICT) in Mumbai
Collaboration with ICT Mumbai will focus on advancing process safety and chemical synthesis in India
Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium PharmaceuticalsCambridge, UK, 12 March 2025:&
Gyles Brandreth urges public to Support CBM UK’s World in Focus Campaign to end avoidable sight loss
Broadcaster and writer Gyles Brandreth is lending his passionate support to Cambridge based, Global Disability Inclusion charity, CBM UK’s World in Focus campaign, highlighting the urgent need to tackle avoidable sight loss affecting 1.1 billion people worldwide.